Cy4gate (CY4) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
7 May, 2026Company overview and market positioning
Operates as a 360° cyber vendor with proprietary technology and solutions for cyber intelligence and cybersecurity markets, targeting governments, large corporations, and SMEs.
Holds a unique position across all three major market segments, offering tailor-made solutions and maintaining a global presence.
Invests in human capital and talent development, and pursues growth through partnerships and M&A activities.
Listed on the STAR Market of the Italian Stock Exchange since June 2023.
Market opportunities and portfolio
Serves fast-growing markets in defense, law enforcement, and corporate sectors, with double-digit growth rates projected in digital transformation and cybersecurity.
Portfolio includes cyber intelligence, decision intelligence, forensic intelligence, and cybersecurity products and services.
Global cyber intelligence and forensic intelligence markets are expected to grow at 10–20% CAGR through 2027.
Cybersecurity products and services markets are forecasted to grow at 9% CAGR through 2027.
Strategic outlook and growth actions
Strategy focuses on strengthening partnerships, expanding geographically, and increasing market penetration in Italy and Europe.
Emphasizes up-selling, cross-selling, and leveraging acquisitions (e.g., XTN) to access new corporate segments.
Aims to capture EU funds for R&D and participate in international consortia for defense programs.
Targets recurring revenue streams and seasonality mitigation through expanded corporate presence.
Latest events from Cy4gate
- Strong growth in cyber intelligence and security, targeting €84–90M revenues in 2024.CY4
Investor presentation7 May 2026 - Achieved 5.8% revenue growth in 9M 2024, expanding in cyber markets and advancing ESG goals.CY4
Investor presentation7 May 2026 - Achieved 10% revenue growth in 2024, with strong defense sector and ESG commitments.CY4
Investor presentation7 May 2026 - H1 2025 saw 30% revenue growth, margin expansion, and strengthened ESG commitments.CY4
Investor presentation7 May 2026 - Strong 2025 growth in forensic and decision intelligence, with robust financial and ESG progress.CY4
Investor presentation7 May 2026 - Strong growth, improved margins, and robust backlog support a positive 2026 outlook.CY4
Q4 20257 May 2026 - Double-digit growth, record new orders, and improved EBITDA margin support 2025 guidance.CY4
Q1 20257 May 2026 - H1 2024 saw lower revenues and a wider net loss, but €84–90M FY 2024 guidance is confirmed.CY4
Q2 20247 May 2026 - Revenues and EBITDA rose, margin improved, but net financial debt increased.CY4
Q3 20247 May 2026